257 related articles for article (PubMed ID: 26882630)
1. Prescription Omega-3 Fatty Acid Products and Dietary Supplements Are Not Interchangeable.
Hilleman D; Smer A
Manag Care; 2016 Jan; 25(1):46-52. PubMed ID: 26882630
[TBL] [Abstract][Full Text] [Related]
2. Omega-3 Fatty Acid Formulations in Cardiovascular Disease: Dietary Supplements are Not Substitutes for Prescription Products.
Fialkow J
Am J Cardiovasc Drugs; 2016 Aug; 16(4):229-239. PubMed ID: 27138439
[TBL] [Abstract][Full Text] [Related]
3. Differentiating prescription omega-3-acid ethyl esters (P-OM3) from dietary-supplement omega-3 fatty acids.
Brunton S; Collins N
Curr Med Res Opin; 2007 May; 23(5):1139-45. PubMed ID: 17519081
[TBL] [Abstract][Full Text] [Related]
4. Long chain omega-3 dietary supplements: a review of the National Library of Medicine Herbal Supplement Database.
Zargar A; Ito MK
Metab Syndr Relat Disord; 2011 Aug; 9(4):255-71. PubMed ID: 21787228
[TBL] [Abstract][Full Text] [Related]
5. Omega-3 fatty acid exposure with a low-fat diet in patients with past hypertriglyceridemia-induced acute pancreatitis; an exploratory, randomized, open-label crossover study.
Dunbar RL; Gaudet D; Davidson M; Rensfeldt M; Yang H; Nilsson C; Kvarnström M; Oscarsson J
Lipids Health Dis; 2020 May; 19(1):117. PubMed ID: 32473640
[TBL] [Abstract][Full Text] [Related]
6. Update on marine omega-3 fatty acids: management of dyslipidemia and current omega-3 treatment options.
Weintraub H
Atherosclerosis; 2013 Oct; 230(2):381-9. PubMed ID: 24075771
[TBL] [Abstract][Full Text] [Related]
7. Prescription omega-3 fatty acid products containing highly purified eicosapentaenoic acid (EPA).
Brinton EA; Mason RP
Lipids Health Dis; 2017 Jan; 16(1):23. PubMed ID: 28137294
[TBL] [Abstract][Full Text] [Related]
8. PUFA for human health: diet or supplementation?
Abete P; Testa G; Galizia G; Della-Morte D; Cacciatore F; Rengo F
Curr Pharm Des; 2009; 15(36):4186-90. PubMed ID: 20041820
[TBL] [Abstract][Full Text] [Related]
9. A novel, multi-ingredient supplement to manage elevated blood lipids in patients with no evidence of cardiovascular disease: a pilot study.
Hobbs T; Caso R; McMahon D; Nymark M
Altern Ther Health Med; 2014; 20(5):18-23. PubMed ID: 25141367
[TBL] [Abstract][Full Text] [Related]
10. Systemic Bioavailability and Dose Proportionality of Omega-3 Administered in Free Fatty Acid Form Compared With Ethyl Ester Form: Results of a Phase 1 Study in Healthy Volunteers.
Offman E; Davidson M; Abu-Rashid M; Chai P; Nilsson C
Eur J Drug Metab Pharmacokinet; 2017 Oct; 42(5):815-825. PubMed ID: 28116646
[TBL] [Abstract][Full Text] [Related]
11. Role of prescription omega-3 fatty acids in the treatment of hypertriglyceridemia.
McKenney JM; Sica D
Pharmacotherapy; 2007 May; 27(5):715-28. PubMed ID: 17461707
[TBL] [Abstract][Full Text] [Related]
12. Critical Differences Between Dietary Supplement and Prescription Omega-3 Fatty Acids: A Narrative Review.
Hilleman DE; Wiggins BS; Bottorff MB
Adv Ther; 2020 Feb; 37(2):656-670. PubMed ID: 31919792
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular disease and omega-3s: Prescription products and fish oil dietary supplements are not the same.
Gutstein AS; Copple T
J Am Assoc Nurse Pract; 2017 Dec; 29(12):791-801. PubMed ID: 29280361
[TBL] [Abstract][Full Text] [Related]
14. Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association.
Skulas-Ray AC; Wilson PWF; Harris WS; Brinton EA; Kris-Etherton PM; Richter CK; Jacobson TA; Engler MB; Miller M; Robinson JG; Blum CB; Rodriguez-Leyva D; de Ferranti SD; Welty FK;
Circulation; 2019 Sep; 140(12):e673-e691. PubMed ID: 31422671
[TBL] [Abstract][Full Text] [Related]
15. Overview of omega-3 Fatty Acid therapies.
Bradberry JC; Hilleman DE
P T; 2013 Nov; 38(11):681-91. PubMed ID: 24391388
[TBL] [Abstract][Full Text] [Related]
16. Effects of Food on the Pharmacokinetics of Omega-3-Carboxylic Acids in Healthy Japanese Male Subjects: A Phase I, Randomized, Open-label, Three-period, Crossover Trial.
Shimada H; Nilsson C; Noda Y; Kim H; Lundström T; Yajima T
J Atheroscler Thromb; 2017 Sep; 24(9):980-987. PubMed ID: 28344197
[TBL] [Abstract][Full Text] [Related]
17. A Single-dose, Comparative Bioavailability Study of a Formulation containing OM3 as Phospholipid and Free Fatty Acid to an Ethyl Ester Formulation in the Fasting and Fed States.
Lapointe JF; Harvey L; Aziz S; Jordan H; Hegele RA; Lemieux P
Clin Ther; 2019 Mar; 41(3):426-444. PubMed ID: 30799231
[TBL] [Abstract][Full Text] [Related]
18. Omega-3 fatty acids and cardiovascular disease: new developments and applications.
Harris WS; Dayspring TD; Moran TJ
Postgrad Med; 2013 Nov; 125(6):100-13. PubMed ID: 24200766
[TBL] [Abstract][Full Text] [Related]
19. Prescription omega-3 fatty acid products: considerations for patients with diabetes mellitus.
Tajuddin N; Shaikh A; Hassan A
Diabetes Metab Syndr Obes; 2016; 9():109-18. PubMed ID: 27143943
[TBL] [Abstract][Full Text] [Related]
20. Overview of prescription omega-3 fatty acid products for hypertriglyceridemia.
Weintraub HS
Postgrad Med; 2014 Nov; 126(7):7-18. PubMed ID: 25387209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
